A shift of alanine to threonine at codon 152 in MAPT might confer a new phosphorylation site, leading to impaired MT binding, disordered retrograde axon transport and an increased risk for primary and secondary tauopathies [109]. The gene discussed is MAPT; the disease is tauopathy.